Doctor profile · Federal record
Dr. ASHWINI VAIDYA, MD
Dermatology Physician (CMS: DERMATOLOGY) · Procedural Dermatology Physician · TULSA, OK
- NPI 1063495380
- Accepts Medicare
- MIPS 90.8 / 100 · 2023
- 27 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2121 E 21ST ST
TULSA, OK 741141409
(918) 749-2261
fax (918) 749-8712 - Mailing address
-
PO BOX 52588
TULSA, OK 741520588
Credentials & registration
- NPI registered
- November 2005 — 21 yrs on file
- Profile last updated
- October 11, 2012
- Year of graduation
- 1999 — 27 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Oklahoma #23219
- Medicaid
- OK #100749090B
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1063495380. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,834
Distinct HCPCS
10
Medicare allowed
$236,576
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 2,093 | 385 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 893 | 659 | $85 | |
17000 |
Destruction of precancer skin growth, 1 growth | 708 | 523 | $50 | |
17110 |
Destruction of skin growth, 1-14 growths | 263 | 230 | $103 | |
11102 |
Biopsy of related skin growth, first growth | 250 | 203 | $84 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 241 | 197 | $121 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 68 | 68 | $105 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 60 | 58 | $53 | |
11103 |
Biopsy of related skin growth, each additional growth | 50 | 35 | $46 | |
17111 |
Destruction of skin growth, 15 or more growths | 50 | 39 | $121 |
In context: peer comparison
Among 10 peers in this city , average services per provider: 240. This provider delivers 20× the peer median.Open Payments
Industry payments received
All-time total
$2,351
Transactions
124
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 22 | $443.30 | |
| Janssen Biotech, Inc. | 13 | $225.27 | |
| Regeneron Healthcare Solutions, Inc. | 8 | $195.75 | |
| Amgen Inc. | 7 | $190.98 | |
| Novartis Pharmaceuticals Corporation | 10 | $190.18 | |
| Lilly USA, LLC | 11 | $172.01 | |
| E.R. Squibb & Sons, L.L.C. | 11 | $160.42 | |
| Incyte Corporation | 11 | $157.22 | |
| Arcutis Biotherapeutics, Inc. | 12 | $145.91 | |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 4 | $76.39 | |
| Galderma Laboratories, L.P. | 5 | $73.76 | |
| LEO Pharma Inc. | 3 | $67.05 | |
| Verrica Pharmaceuticals Inc. | 3 | $63.11 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $44.91 | |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $38.85 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
759
Patients
396
Total drug cost
$29,061
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Finasteride | Generic | 141 | 37 | $1,479 |
| Triamcinolone Acetonide | Generic | 104 | 77 | $1,096 |
| Clobetasol Propionate | Generic | 90 | 49 | $8,980 |
| Hydrocortisone | Generic | 72 | 51 | $479 |
| Fluorouracil | Generic | 60 | 57 | $5,715 |
| Minocycline Hcl | Generic | 43 | 13 | $924 |
| Nystatin | Generic | 42 | 25 | $707 |
| Ketoconazole | Generic | 36 | 20 | $920 |
| Doxycycline Hyclate | Generic | 32 | 0 | $1,015 |
| Betamethasone Dipropionate | Generic | 31 | 21 | $1,630 |